REGISTER NOW FOR ANS BIOTECH NEXT WEBINAR, JUNE 24TH
Osteoarthritis pain: mechanisms and pharmacology Register now! Osteoarthritis (OA) of the knee is a complex peripheral joint disorder. This degenerative disease involving several joint tissues is characterized by damages to the articular cartilage. Pain is the primary symptom of OA and is the driving factor for patients to seek medical help. OA-associated pain is described [...]
One month remaining before digital BIO US 2021! On June 14-18, Yassine will attend BIO International Convention Digital 2021. He will be pleased to evaluate whether the in vivo services offered by ANS Biotech can be helpful for your research projects. Without further delay, join him to the event!
Last chance to schedule an e-meeting with Julie and Yassine directly on the platform of the event : https://informaconnect.com/bioeurope-spring/ ! They look forward to discussing with you about your Pain project and the possibility to start a great and promising collaboration!
Surgical wounds-induced postoperative pain is our model of the month! The incisional pain model allows the assessment of the mechanisms of increased mechanical sensitivity following a surgical incision and is widely used for revealing the potency of new analgesics in this clinical situation.
Partial Restraint Stress-induced visceral hypersensitivity is our model of the month! Irritable bowel syndrome (IBS) is mainly characterized by abdominal pain impacting the quality of life. Various psychological stressors maybe responsible for the visceral hypersensitivity experienced by IBS patients.
François Caussade, fondateur d’ANS Biotech, raconte son histoire, parmi 30 portraits d'entrepreneurs, dans le livre « We are Busi », une production de BUSI Incubateur, premier incubateur d’entreprises en France. Click here to access the full article.
ANS Biotech has successfully renewed its ISO 9001-2015 certification. The company is ISO 9001 certified since 2014 and maintains every day the highest quality standards for its Customers’ satisfaction.
Register Now for ANS Biotech webinar, September 17th
"Pharmacology and mechanisms of Oxaliplatin-induced neuropathic pain" by our CSO, Laurent DIOP. During this webinar, we will discuss: Clinical syndrome and diagnosis Mechanisms of CIPN Pharmacology and treatment Attendance is free, but registration is required. REGISTER NOW
Save the date! Next ANS Biotech Webinar on September 17th, 2020. “Pharmacology and mechanisms of Oxaliplatin-induced neuropathic pain” by our CSO: Laurent Diop. Happy to share a valuable time with you!
In the current global health context, ANS Biotech is mobilizing and adapting so as not to stop its support in the services for its Customers. We remain available online and fully mobilized for your projects.
We are pleased to announce that ANS Biotech is now an official registered vendor on the Science Exchange platform! Visit our Provider profile (https://www.scienceexchange.com/labs/ans-biotech) and easily start a collaboration with us!
17 th World Congress on Pain in Boston, MA (September 12-16, 2018)
ANS Biotech attended 17th World Congress on Pain in Boston, MA (September 12-16, 2018). ANS Biotech presented a poster titled: Comparison of the antinociceptive and antipruritic effects of kappa opioid receptor agonists on models of itch and pain.